Demanding fairer prices for drugs

18 October 2013
protest-big

South Africa’s patent protests

Hundreds of people marched through the streets of South Africa’s capital Pretoria on Thursday as the Fix the Patent Laws campaign asked the government to amend the country’s Patents Act. Led by Médecins Sans Frontières, the Treatment Action Campaign and Section27, the campaign wants flexibility introduced in patent laws so that South Africa can lower the prices of existing medicines. The government launched a public consultation on its draft policy changes and invited comment before it reaches a final decision. The campaign has accused the government of blindly handing out patents without checking whether they meet the terms of the act, blocking the possibility of generic alternatives. That so many people joined the organizations on the streets of the city demonstrates how emotive this issue is in the country. Engaging ordinary people in an issue like this is a clear sign for South Africa’s government that something has to change.

Financial results show upturn

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight